Ertapenem+Meropenem Including Double Carbapenem Therapy (EMDCT) Versus Ceftazidime-Avibactam Therapy In The Therapy Of Carbapenem-Resistant Klebsiella Pneumoniae Infections (CRKPI): A Retrospective Matched Cohort Study

Ertapenem+Meropenem Including Double Carbapenem Therapy (EMDCT) Versus Ceftazidime-Avibactam Therapy In The Therapy Of Carbapenem-Resistant Klebsiella Pneumoniae Infections (CRKPI): A Retrospective Matched Cohort Study

BACKGROUND-AIM: In this retrospective matched cohort study, we aimed to compare the clinical outcomes of EMDCT including therapy receiving cases with ceftazidime/avibactam (CAZAVI) receiving CRKPI cases. MATERIALS/METHODS: This study was performed at a 1800+ bedded tertiary-care educational universi...

Full description

Saved in:
Bibliographic Details
Main Authors: Merve Mert Vahabi, Deniz Dağ, Şevket Yeniyol, Gamze Şanlıdağ, Deniz Akyol, Seichan Ketentzi, Dilşah Başkol, Buse Kenanoğlu, Nazlıhan Yalçın, Şükrü Dirik, Arda Kaya, Uğur Önal, Hüseyin Aytaç Erdem, Hüsnü Pullukçu, Meltem Taşbakan, Tansu Yamazhan, Bilgin Arda, Sercan Ulusoy, Oğuz Reşat Sipahi
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Journal of Global Antimicrobial Resistance
Subjects:
multidrug resistance
carbapenem resistance
carbapenems
Online Access:http://www.sciencedirect.com/science/article/pii/S2213716524001851
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2213716524001851

Similar Items